Ozempic (semaglutide) follows a gradual titration schedule designed to minimize side effects while building to a therapeutically effective dose. Starting low and increasing slowly is the key to tolerability — patients who rush the schedule experience significantly more nausea, vomiting, and GI distress. The standard schedule spans at least 8-16 weeks before reaching the maintenance dose that produces meaningful weight loss and glucose control.
Standard Titration Schedule
Weeks 1-4: 0.25mg weekly. This is the initiation dose. It's not intended to produce significant weight loss or glucose reduction — it exists solely to let your body adjust to the medication. Some people notice mild appetite suppression. GI side effects, if present, are usually mild.
Weeks 5-8: 0.5mg weekly. The first therapeutic dose. Most people begin noticing appetite suppression and some weight loss here. GI side effects may resurface or intensify briefly as the dose increases, then typically settle within 2-3 weeks.
Weeks 9+: 1mg weekly. The standard maintenance dose for diabetes. For weight loss, many prescribers keep patients here if it's producing adequate results. Side effects are usually well-established and manageable by this point.
Optional: 2mg weekly. Added in 2022 for patients needing additional glycemic or weight loss benefit. Not everyone needs this dose. Discuss with your prescriber whether the incremental benefit justifies the potential increase in side effects.
For weight management specifically, Wegovy (semaglutide at 2.4mg) follows its own titration schedule with additional intermediate steps.
Injection Technique
Ozempic is self-injected subcutaneously (under the skin) once weekly. Recommended sites: abdomen (2+ inches from navel), thigh, or upper arm. Rotate injection sites. The pen comes pre-filled with a twist-dial mechanism — you select the dose, press the pen against your skin, and push the button.
Tips: inject at the same time each week (pick a consistent day). If you miss a dose by fewer than 5 days, take it as soon as you remember. If more than 5 days, skip and take the next scheduled dose. Don't double up.
What to Expect at Each Stage
First Month (0.25mg)
Mild appetite changes. Possible light nausea. This is adjustment, not treatment. Don't judge the medication's effectiveness at this dose.
Months 2-3 (0.5-1mg)
Appetite suppression becomes noticeable. Portion sizes naturally decrease. You might feel full after half your usual meal. GI side effects peak with each increase, then settle. Weight loss becomes visible — typically 2-5 lbs/month at 0.5mg, accelerating at 1mg.
Months 4+ (1-2mg)
Steady state. If the medication is working, appetite is reliably reduced, caloric intake is lower without constant willpower, and weight loss continues at 1-2% of body weight per month. Plateau is normal and expected as your body adjusts to a new lower weight.
When Titration Goes Wrong
Increasing too fast — jumping from 0.25 to 1mg, or skipping the 0.5mg step — produces severe nausea, vomiting, and sometimes dehydration requiring medical attention. There's no advantage to rushing; the medication takes weeks to reach steady state at each dose, and your body needs time to adapt to slowed gastric motility.
Some patients need slower titration — spending 6-8 weeks at each dose instead of 4. This is perfectly acceptable and may be preferable for people with GI sensitivity. Your prescriber should adjust the schedule to your tolerance rather than rigidly following the standard timeline.
Storage and Handling
Unused pens: refrigerate (36-46°F). In-use pens: room temperature (up to 86°F) for up to 56 days. Don't freeze. Don't expose to extreme heat. Keep the cap on when not in use. Discard after 56 days regardless of remaining medication.
Understanding how GLP-1 medications work can help you make sense of the titration process and set realistic expectations. Combining the medication with proper nutritional support maximizes your results at every dose level.